Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22–CCR4 axis

Previous studies have found that tumor-associated macrophages (TAMs) promote cancer progression. We previously reported that TAMs promote prostate cancer metastasis via activation of the CCL2–CCR2 axis. The CCR4 (receptor of CCL17 and CCL22) expression level in breast cancer was reported to be associated with lung metastasis. The aim of this study was to elucidate the role of CCR2 and CCR4 in prostate cancer progression. CCR2 and CCR4 were expressed in human prostate cancer cell lines and prostate cancer tissues. In vitro co-culture of prostate cancer cells and macrophages resulted in increased CCL2 and CCR2 levels in prostate cancer cells. The addition of CCL2 induced CCL22 and CCR4 production in prostate cancer cells. The migration and invasion of prostate cancer cells via enhanced phosphorylation of Akt were promoted by CCL17 and CCL22. CCR4 may be a potential candidate for molecular-targeted therapy.

• Publication year

  2016

• Venue

  OncoTarget

• Publication date

  2016-12-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.18632/oncotarget.14185PMID 28039457PMCID 5354767
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostate Cancer

  2018cited by this paper
• Cancer statistics, 2016

  2016cited by this paper
• The relationship between prostate‐specific antigen and TNM classification or Gleason score in prostate cancer patients with low prostate‐specific antigen levels

  2015cited by this paper
• Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer

  2015cited by this paper
• Acquisition of an immunosuppressive protumorigenic macrophage phenotype depending on c-Jun phosphorylation

  2014cited by this paper
• Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer.

  2014cited by this paper
• Optimal treatment for castration-resistant prostate cancer

  2014cited by this paper
• Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen level

  2014cited by this paper
• Infiltrating macrophages promote prostate tumorigenesis via modulating androgen receptor-mediated CCL4-STAT3 signaling.

  2013cited by this paper
• Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling

  2013cited by this paper
• Targeting inflammatory cytokines-androgen receptor (AR) signaling with ASC-J9® to better battle prostate cancer progression

  2013cited by this paper
• Exogenous SPARC Suppresses Proliferation and Migration of Prostate Cancer by Interacting With Integrin β1

  2013cited by this paper
• Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation

  2013cited by this paper
• ) Relationship between

  2009cited by this paper
• The TGF-beta, PI3K/Akt and PTEN pathways: established and proposed biochemical integration in prostate cancer.

  2009cited by this paper
• Breast cancer lung metastasis requires expression of chemokine receptor CCR4 and regulatory T cells.

  2009cited by this paper
• CCL2 Protects Prostate Cancer PC3 Cells from Autophagic Death via Phosphatidylinositol 3-Kinase/AKT-dependent Survivin Up-regulation*

  2008cited by this paper
• Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo.

  2007cited by this paper
• AKT/PKB signaling: navigating downstream.

  2007cited by this paper
• CCR2 expression correlates with prostate cancer progression

  2007cited by this paper
• G protein‐coupled receptor‐induced Akt activity in cellular proliferation and apoptosis

  2007cited by this paper
• CCL2 is a potent regulator of prostate cancer cell migration and proliferation.

  2006cited by this paper
• Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy.

  2006cited by this paper
• Chemokines in tumor progression and metastasis

  2005cited by this paper
• Akt-regulated pathways in prostate cancer

  2005cited by this paper
• Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases

  2004cited by this paper
• The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity.

  2003cited by this paper
• Chemokines in cancer.

  2002cited by this paper
• Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes.

  2002cited by this paper
• Chemokines in cancer

  2001cited by this paper
• Low-Level Monocyte Chemoattractant Protein-1 Stimulation of Monocytes Leads to Tumor Formation in Nontumorigenic Melanoma Cells1

  2001cited by this paper
• Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer.

  2000cited by this paper
• The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer.

  1995cited by this paper
• Prostate cancer. Primary hormonal treatment

  1993cited by this paper
• Tumor infiltrating cells in human cancer. On the possible role of CD16+ macrophages in antitumor cytotoxicity.

  1992cited by this paper
• Cancer statistics

  1989cited by this paper

• Vitamin D modulates the basal secretion of inflammatory cytokines in breast cancer cells: An in-vitro study.

  2026cites this paper
• Whole‐Blood RNA Expression of Immunosuppressive Cell‐Related Genes Is Associated With Prostate Cancer Progression

  2025cites this paper
• The Use of Biologics for Targeting GPCRs in Metastatic Cancers

  2025cites this paper
• Androgen Receptor‐Controlled microRNA‐124‐3p.2 Suppresses Prostate Cancer Progression via CCL2 Inhibition

  2025cites this paper
• Regulatory T Cell Attracting Therapy Accelerates Skeletal Muscle Functional Recovery Following Injury

  2025cites this paper
• CCL2/CCR2 signaling pathway in tumorigenesis and metastasis (Review)

  2025cites this paper
• Colorectal cancer relies on an immunosuppressive cellular topography and genomic adaptations for establishing brain metastases

  2025cites this paper
• IL-6 secreted by tumor-associated macrophages promotes proliferation and migration through JAK2/STAT3 signaling pathway in human prostate cancer cells

  2025cites this paper
• Therapeutic Advances in Metastatic Prostate Cancer: A Journey from Standard of Care to New Emerging Treatment

  2025cites this paper
• Cytochrome P450 genes expression in human prostate cancer.

  2024cites this paper
• Engineering Biomaterials to Model Immune‐Tumor Interactions In Vitro

  2024cites this paper
• Effect of nonsteroidal anti‐inflammatory drugs (aspirin and naproxen) on inflammation‐associated proteomic profiles in mouse plasma and prostate during TMPRSS2‐ERG (fusion)‐driven prostate carcinogenesis

  2024cites this paper
• Fu-Zheng-Yi-Liu Formula inhibits the stem cells and metastasis of prostate cancer via tumor-associated macrophages/C-C motif chemokine ligand 5 pathway in tumor microenvironment.

  2024cites this paper
• High-dimensional mapping of human CEACAM1 expression on immune cells and association with melanoma drug resistance

  2024cites this paper
• Secreted factors from M1 macrophages drive prostate cancer stem cell plasticity by upregulating NANOG, SOX2, and CD44 through NFκB-signaling

  2024cites this paper
• CCL22 as an independent prognostic factor in endometrial cancer patients

  2024cites this paper
• Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis

  2024cites this paper
• Targeting the prostate tumor microenvironment by plant-derived natural products.

  2023cites this paper
• Osteoid cell-derived chemokines drive bone-metastatic prostate cancer

  2023cites this paper
• Impact of Immune Cells in the Tumor Microenvironment of Prostate Cancer Metastasis

  2023cites this paper
• Establishing a Proteomics-Based Signature of AKR1C3-Related Genes for Predicting the Prognosis of Prostate Cancer

  2023cites this paper
• What should be the future direction of development in the field of prostate cancer with lung metastasis?

  2023cites this paper
• CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing Mice

  2023cites this paper
• Applications of Pyrrole and Pyridine-based Heterocycles in Cancer Diagnosis and Treatment.

  2023cites this paper
• Downstream STING pathways IRF3 and NF-κB differentially regulate CCL22 in response to cytosolic dsDNA

  2023cites this paper
• The role of NFATc1 in the progression and metastasis of prostate cancer: A review on the molecular mechanisms and signaling pathways

  2023cites this paper
• A genome-wide CRISPR screen in human prostate cancer cells reveals drivers of macrophage-mediated cell killing and positions AR as a tumor-intrinsic immunomodulator

  2023cites this paper
• New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer

  2023cites this paper
• IMMUNOTHERAPY Mogamulizumab in Combination with Nivolumab in a Phase I/II Study of Patients with Locally Advanced or Metastatic Solid Tumors

  2022cites this paper
• Triple-negative breast cancer influences a mixed M1/M2 macrophage phenotype associated with tumor aggressiveness

  2022cites this paper
• Identification of the Binding Epitope of an Anti-mouse CCR4 Monoclonal Antibody, C4Mab-1

  2022cites this paper
• Slit2/Robo1 signaling inhibits small‐cell lung cancer by targeting β‐catenin signaling in tumor cells and macrophages

  2022cites this paper
• Transcriptome analysis of SerpinB2-deficient breast tumors provides insight into deciphering SerpinB2-mediated roles in breast cancer progression

  2022cites this paper
• Regulation of intrinsic and extrinsic metabolic pathways in tumour‐associated macrophages

  2022cites this paper
• Chemokines and Cytokines: Axis and Allies in Prostate Cancer Pathogenesis.

  2022cites this paper
• Targeting Epithelial-to-Mesenchymal Transition in Radioresistance: Crosslinked Mechanisms and Strategies

  2022cites this paper
• Cancer Prevention Effects of Foods, Food Groups, Nutrients, and Their Underlying Mechanisms

  2022cites this paper
• Chemokines network in bone metastasis: Vital regulators of seeding and soiling.

  2022cites this paper
• Effects of dietary omega-3 fatty acids on orthotopic prostate cancer progression, tumor associated macrophages, angiogenesis and T-cell activation—dependence on GPR120

  2022cites this paper
• Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?

  2022cites this paper
• MLL1 regulates cytokine-driven cell migration and metastasis

  2022cites this paper
• Engineering in vitro immune-competent tissue models for testing and evaluation of therapeutics.

  2022cites this paper
• The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors

  2022cites this paper
• Tailoring biomaterials and applications targeting tumor-associated macrophages in cancers

  2022cites this paper
• Suppression of androgen receptor signaling induces prostate cancer migration via activation of the CCL20–CCR6 axis

  2022cites this paper
• Expresion paterns of various PDCD1 and PDL1 isoforms in prostate tumors

  2022cites this paper
• Lineage plasticity in prostate cancer: Looking beyond intrinsic alterations.

  2022cites this paper
• Prostate cancer immunotherapy: a review of recent advancements with novel treatment methods and efficacy.

  2022influential citation
• The immune cell infiltrate in the tumour microenvironment of phaeochromocytomas and paragangliomas

  2022cites this paper
• Identification of a Tumor Microenvironment-Related Gene Signature Indicative of Disease Prognosis and Treatment Response in Colon Cancer

  2021cites this paper
• 3D Cancer Models: Depicting Cellular Crosstalk within the Tumour Microenvironment

  2021cites this paper
• Novel Combinatorial Approaches to Tackle the Immunosuppressive Microenvironment of Prostate Cancer

  2021cites this paper
• Research trends in pharmacological modulation of tumor‐associated macrophages

  2021cites this paper
• Research Trends and Regulation of CCL5 in Prostate Cancer

  2021cites this paper
• Identification of HCG18 and MCM3AP-AS1 That Associate With Bone Metastasis, Poor Prognosis and Increased Abundance of M2 Macrophage Infiltration in Prostate Cancer

  2021cites this paper
• Fabrication of electrochemical immunosensor based on acid-substituted poly(pyrrole) polymer modified disposable ITO electrode for sensitive detection of CCR4 cancer biomarker in human serum.

  2021cites this paper
• A novel immune-related prognostic signature in epithelial ovarian carcinoma

  2021cites this paper
• Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?

  2021cites this paper
• Mogamulizumab in Combination with Nivolumab in a Phase I/II Study of Patients with Locally Advanced or Metastatic Solid Tumors

  2021cites this paper
• E2F2 stimulates CCR4 expression and activates synovial fibroblast-like cells in rheumatoid arthritis

  2021cites this paper
• Leukocytes from Patients with Drug-Sensitive and Multidrug-Resistant Tuberculosis Exhibit Distinctive Profiles of Chemokine Receptor Expression and Migration Capacity

  2021cites this paper
• Electrochemical Immunosensor for Detection of CCR4 Cancer Biomarker in Human Serum: An Alternative Strategy for Modification of Disposable ITO Electrode.

  2020cites this paper
• Unfolding innate mechanisms in the cancer microenvironment: The emerging role of the mesenchyme

  2020cites this paper
• Pattern of expression of immune- and stroma-associated genes in blood of mice with experimental B16 melanoma

  2020cites this paper
• A review of antibody-based therapeutics targeting G protein-coupled receptors: an update

  2020cites this paper
• CCL5 derived from tumor-associated macrophages promotes prostate cancer stem cells and metastasis via activating β-catenin/STAT3 signaling

  2020cites this paper
• Contribution of Macrophages and T Cells in Skeletal Metastasis

  2020cites this paper
• Modulation of the tumor microenvironment by natural agents: implications for cancer prevention and therapy.

  2020cites this paper
• BML-111 inhibits EMT, migration and metastasis of TAMs-stimulated triple-negative breast cancer cells via ILK pathway.

  2020cites this paper
• THE TUMOUR MICROENVIRONMENT OF PITUITARY NEUROENDOCRINE TUMOURS.

  2020cites this paper
• Blockade of CCR4 DIminishes hypersensitivity and enhances opioid analgesia - evidence from a mouse model of diabetic neuropathy.

  2020cites this paper
• Mogamulizumab in Combination with Durvalumab or Tremelimumab in Patients with Advanced Solid Tumors: A Phase I Study

  2020cites this paper
• Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched Subtypes

  2020cites this paper
• Dual Repressive Function by Cip1, a Budding Yeast Analog of p21, in Cell-Cycle START Regulation

  2020cites this paper
• Long-Noncoding RNA (lncRNA) in the Regulation of Hypoxia-Inducible Factor (HIF) in Cancer

  2020cites this paper
• Current Status and Future Perspectives of Checkpoint Inhibitor Immunotherapy for Prostate Cancer: A Comprehensive Review

  2020cites this paper
• Application of Anti-Inflammatory Agents in Prostate Cancer

  2020cites this paper
• Macrophage-derived exosomes attenuate the susceptibility of oral squamous cell carcinoma cells to chemotherapeutic drugs through the AKT/GSK-3β pathway

  2020cites this paper
• Androgen receptor signalling in macrophages promotes TREM-1-mediated prostate cancer cell line migration and invasion

  2020cites this paper
• Metabolic reprograming of tumor-associated macrophages

  2020cites this paper
• The P72R Polymorphism in R248Q/W p53 Mutants Modifies the Mutant Effect on Epithelial to Mesenchymal Transition Phenotype and Cell Invasion via CXCL1 Expression

  2020cites this paper
• The prostate cancer stem cell niche: Genetic drivers and therapeutic approaches

  2020cites this paper
• Is the C-C Motif Ligand 2–C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?

  2020cites this paper
• Co-culture hydrogel micro-chamber array-based plate for anti-tumor drug development at single-element resolution.

  2020cites this paper
• Maximizing the potency of oxaliplatin coated nanoparticles with folic acid for modulating tumor progression in colorectal cancer.

  2020cites this paper
• The Roles of Stroma-Derived Chemokine in Different Stages of Cancer Metastases

  2020cites this paper
• Screening and Identification of Key Microenvironment-Related Genes in Non-functioning Pituitary Adenoma

  2020cites this paper
• From Mutagenesis to Metastasis: A General Description of Cancer Development

  2019cites this paper
• Tumor-Associated Macrophages Induce Migration of Renal Cell Carcinoma Cells via Activation of the CCL20-CCR6 Axis

  2019cites this paper
• The Prostate

  2019cites this paper
• Non-nuclear AR Signaling in Prostate Cancer

  2019cites this paper
• Circ_0039569 promotes renal cell carcinoma growth and metastasis by regulating miR-34a-5p/CCL22.

  2019cites this paper
• Prostate Cancer- The Role of Inflammation and Chemokines.

  2019cites this paper
• Heterogeneity of human prostate carcinoma‐associated fibroblasts implicates a role for subpopulations in myeloid cell recruitment

  2019cites this paper
• Photoacoustic imaging of clofazimine hydrochloride nanoparticle accumulation in cancerous vs normal prostates

  2019cites this paper
• Profiling chemokine signalling bias of CCR4, CCR7 and CCR10

  2019cites this paper
• Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells

  2019cites this paper
• CC chemokines are differentially expressed in Breast Cancer and are associated with disparity in overall survival

  2019cites this paper
• MOLECULAR PROFILING OF PROSTATE TUMORS

  2018cites this paper
• CCL17‐CCR4 axis promotes metastasis via ERK/MMP13 pathway in bladder cancer

  2018cites this paper